Other Clinical Trial - The Effect of Amantadine on Post-COVD-19 Fatigue

Status Not yet recruiting

Clinical Trial Summary

This study aimed to investigate amantadine's safety and its effect on reducing post-COVID-19 fatigue.

Clinical Trial Description

Background The 2019 coronavirus disease has severely affected the health of the general public. Even after recovery, this disease can cause problems, including chronic fatigue, which the patient can suffer from for years and cause permanent disability for a number of patients. Despite the fact that fatigue due to COVID-19 has affected many patients, not many studies have been done in the field of effective treatment for this problem. In this study, the investigators studied the effect of amantadine on the fatigue of COVID-19 patients. Method In this clinical trial study, 83 patients were randomly included in the study from the patients referred to the internal clinic of Shohada Tajrish Hospital in Tehran, and they were initially evaluated by VAFS and FSS questionnaires. 17 patients were initially excluded due to having at least one exclusion criterion. And 66 patients were randomly divided between two groups using amantadine and the control group. The amantadine group was treated with amantadine capsules 100 mg BD for 2 weeks and after 2 weeks again for both The group questionnaire was completed, and the data was analyzed by SPSS software version 26. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05667077
Study type	Interventional
Source	Shahid Beheshti University of Medical Sciences
Contact
Status	Not yet recruiting
Phase	Phase 2
Start date	December 26, 2022
Completion date	January 10, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06073002` - Effects of a Home-Based Exercise Intervention in Subjects With Long COVID	N/A
Completed	`NCT05047952` - Vortioxetine for Post-COVID-19 Condition	Phase 2
Completed	`NCT05812209` - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Recruiting	`NCT06091384` - Inspiratory Muscle Strength Training in Post-Covid Syndrome	N/A
Not yet recruiting	`NCT06267300` - Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial	Phase 3
Recruiting	`NCT05986422` - Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)	Phase 2
Not yet recruiting	`NCT05534997` - Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome	N/A
Recruiting	`NCT05638633` - Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome	Phase 3
Active, not recruiting	`NCT05630040` - VNS for Long-COVID-19	N/A
Recruiting	`NCT05841498` - Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome	N/A
Enrolling by invitation	`NCT05981872` - EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19	N/A
Active, not recruiting	`NCT05543408` - Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"	N/A
Recruiting	`NCT05817032` - Effect of Telerehabilitation Practice in Long COVID-19 Patients	N/A
Recruiting	`NCT05823896` - imPROving Quality of LIFe In the Long COVID Patient	Phase 2
Completed	`NCT05764070` - Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients	N/A
Completed	`NCT05765591` - Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome	N/A
Recruiting	`NCT05918965` - Vagus Stimulation in Female Long COVID Patients.	N/A
Not yet recruiting	`NCT06231238` - Balance Acceptance and Commitment Therapy for Long COVID	Phase 2
Completed	`NCT06282627` - The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
Completed	`NCT05648734` - Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis